antibodies to ionotropic glutamate receptors. Here, IgG isolated from brain of infected mice has been tested electrophysiologically on cultured rat cortical and hippocampal neurons. The IgG elicited glycine-independent currents that reversed at ϳ0 mV. Equivalent concentrations of IgG from uninfected mice were inactive. The glycine-independent currents were less influenced by DNQX and GYKI-52466 than currents elicited by AMPA and KA. The IgG also elicited glycine-dependent currents that reversed at ؊10 mV and were blocked by dl-AP5, 5,7-DCKA, and polyamine amides. Glycinedependent and -independent currents were unaffected by tetrodotoxin, strychnine, the transmembrane Cl ؊ gradient or d-tubocurare. Although part of the glycine-independent current remains uncharacterized, these results confirm that a virus-induced immunopathology produces IgG clones that activate ionotropic glutamate receptors and that could, thereby, contribute to the excitotoxic neurological syndrome observed in LP-BM5-infected mice.
INTRODUCTION
Ionotropic glutamate receptors are multimeric membrane proteins mediating fast transmission at synapses in mammalian brain. They have been classified, using pharmacological and molecular biological criteria, into N-methyl-d-aspartate (NMDA) receptors and non-NMDA receptors. The latter are subdivided into those that have a high affinity for ␣-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) but also bind kainic acid (KA) (GluR1-4 subunits), those that bind KA but have a low affinity for AMPA (GluR5-7 subunits) and those that bind only KA (KA1-2 subunits) (Hollmann and Heinemann, 1994) . Persistent activation of ionotropic glutamate receptors in both acute and chronic neurodegenerative diseases such as stroke, trauma, and AIDS dementia complex can lead to neuronal dysfunction and death (Choi, 1988; Meldrum and Garthwaite, 1990; Green et al., 1996; Lipton and Gendelman, 1995) . While the principal mediator of these excitotoxic processes is glutamate, recent evidence suggests that antibodies that can activate AMPA receptors may contribute to chronic neurodegenerative diseases such as Rasmussen's encephalitis (Rogers et al., 1994) , epilepsy (Dambinova et al., 1997) , and nonfamilial olivopontocerebellar atrophy (Gahring et al., 1997) . However, it remains unclear how these anti-self antibodies arise, and by what mechanisms they activate ionotropic glutamate receptors. Animal models of autoimmune neurological syndromes typically require the administration of an adjuvant and a specific protein resembling the selfprotein. Such models include experimental autoimmune encephalomyelitis, induced by the administration of myelin proteolipid apoprotein (Martin and McFarland, 1995) . Also, immunization with an AMPA receptor fragment fusion protein produces syndromes resembling Rasmussen's encephalitis (Rogers et al., 1994) . However, an animal model which produces anti-self antibodies in association with a disease state may allow a better understanding of the 
